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ABSTRACT
PREDICTIVE VALUE OF ADHD SYMPTOMATOLOGY ON
MOTIVES AND OUTCOMES OF STIMULANT MISUSE
Alexander Laszlo Peterkin
Old Dominion University, 2017
Director: Dr. Valerain J. Derlega

ADHD stimulant misuse is defined as taking a stimulant used to treat ADHD either
without having a prescription for that stimulant or in a manner that deviates from the
prescription’s instructions. This has been a growing trend among undergraduate students over
recent years. Prior research has found that misusers are likely to have severe symptoms of
ADHD, misuse for primarily academic reasons, and display problems associated with substance
abuse. The current study aimed to determine the predictive value of ADHD symptomatology on
frequency of ADHD stimulant misuse, mediated by academic motives for misuse and substance
abuse problems. The survey for this study was completed by 1,082 students at a state university
in southeastern Virginia. Data from 184 misusers were analyzed using SEM path analysis. A
significant direct effect was found with ADHD symptomatology on frequency of misuse, and
this effect was mediated by academic motives for misuse, but not by substance abuse problems.
The results suggest that undergraduate students with undiagnosed problems with attention and
hyperactivity might have academic difficulties for which they would turn to ADHD stimulant
misuse as a solution. While not analyzed in this study, such a student, who may already be using
other substances for non-academic reasons, could later develop medical, social, and family
problems associated with substance abuse.
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CHAPTER I
INTRODUCTION
Prescription stimulant medications, such as Ritalin, Adderall, Focalin, Vyvanse, and
Concerta, are typically used to treat attention-deficit/hyperactivity disorder (ADHD; Lakhan &
Kirchgessner, 2012). Recently, however, studies report that undergraduate students nationwide
have sometimes used these medications either without a physician prescription or in a manner
that deviates from prescription instructions, constituting ADHD stimulant misuse (Teter,
McCabe, Cranford, & Boyd, 2005).
Previous work has suggested that ADHD stimulant misuse may represent self-treatment
for undiagnosed ADHD. Peterkin, Crone, Sheridan, and Wise (2011) surveyed 184 students at a
large university in Northern Virginia. The students responded to questions regarding ADHD
symptomatology as measured by the World Health Organization (WHO) Adult ADHD SelfReport Scale (ASRS), ADHD stimulant misuse, motives for misuse, and perceived impact on
grades. Misusers were identified as students who reported taking ADHD medications that had
not been prescribed to them. The researchers found that misusers were seven times more likely to
report severe symptoms of ADHD compared to non-misusers. Additionally, they found that 87%
of misusers cited academic reasons for misuse and 76% indicated that the misuse was improving
their grades (Peterkin et al., 2011). The authors argued for the need to better understand the role
ADHD symptomatology plays in characteristics and outcomes of ADHD stimulant misuse
among undergraduates.
The current study further investigated the notion that ADHD stimulant misuse may be
explained by self-treatment for undiagnosed ADHD using self-reported ADHD symptomatology
to predict the frequency of ADHD stimulant misuse through the mediating mechanisms of
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academic motives of misuse and substance abuse problems. The proposed model for this study
can be seen in Figure 1.

Personal and
Family History

Current
Symptomatology

Past
Symptomatology

Academic Motives
of Misuse

ADHD
Symptomatology

Frequency of
Misuse

Substance
Abuse Problems

Figure 1. Predicted model for direct and indirect effects of ADHD symptom severity on
frequency of ADHD stimulant misuse.
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CHAPTER II
CHARACTERISTICS OF ADHD STIMULANT MISUSE
ADHD is a neurodevelopmental disorder characterized by problems with inattention,
hyperactivity, distractibility, and impulsivity interfering with daily functioning (Matte et al.,
2015). These problems are particularly detrimental in a workplace or school setting, especially
among those who are untreated (Fried et al., 2012). While this disorder is typically perceived to
be a childhood problem and its diagnosis requires childhood onset, approximately half of those
diagnosed continue to display symptoms through adulthood (Lakhan & Kirchgessner, 2012).
Though prevalence rates for ADHD are difficult to interpret due to the nature of sampling and
variability in its diagnosis (Cuffe, Moore, & McKeown, 2005), current national estimates suggest
an adult ADHD prevalence rate of 3-5% (Faraone & Bierderman, 2005; Matte et al., 2015).
Precise rates of undergraduate ADHD stimulant misuse are also hard to obtain. Reports
have documented undergraduate misuse prevalence rates ranging from 8% (Teter et al., 2005) to
48% (Ilieva & Farah, 2015). There are no definitive explanations for these variations, but they
are likely to be due to variability in sampling and how separate researchers identify misusers.
Despite this, it is clear that ADHD stimulant misuse is a significant occurrence within the
undergraduate population. Among undergraduate stimulant misusers, students have reported an
average of 6-9 incidents of stimulant misuse during the span of their undergraduate studies
(Ilieva & Farah, 2015).
A particular characteristic of interest for the current study is the role that ADHD
symptoms play in motivating misuse. Because the stimulants taken by misusers are traditionally
used to treat ADHD, it seems likely that some relationship exists between the decision to misuse
and the experience of ADHD symptoms. In fact, several studies have documented that misusers
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are more likely to report more severe ADHD symptoms than non-misusers (Hartung et al., 2013;
Ilieva & Farah, 2015; Peterkin et al., 2011; Rabiner, Anastopoulos, Costello, Hoyle, &
Swartzwelder, 2010). Additionally, Rabiner and colleagues (2010) found that self-reported
attention difficulties significantly predicted incidents of new onset misuse among college
students over a five week period. However, the relationship between ADHD symptoms and
medication misuse is made more difficult to investigate by problems associated with self-report
data. For example, misusers may self-perceive ADHD symptoms when no attention problems are
actually present. In a study conducted by Ilieva and Farah (2015), self-reported attention
problems and objectively measured attention problems were compared between misusers and
non-misusers. While misusers had significantly higher self-reported attention problems
compared to non-misusers, misusers did not show significantly different problems with omission
errors, reaction time, or commission errors on an objective attention and impulsivity test
compared to non-misusers.
Collectively, prior research literature highlights a fundamental limitation in the accuracy
of self-report determined ADHD diagnoses and symptomatology. A proper clinical diagnosis of
ADHD requires a combination of self-reported symptoms, peer- or family-reported symptoms,
family history, neurological testing, clinical assessment, and diagnostic judgment from a licensed
health care provider with the skills to make this assessment (Barkley, 2014). So while previous
research has found that self-reported attention problems may be related to ADHD stimulant
misuse, self-report alone is insufficient to diagnose ADHD. This is, in fact, a limitation of the
current study as well. However, the current study improves upon this self-report process by
inquiring about a childhood and family history of these symptoms. This study acknowledges the
diagnostic limitation and does not purport to show a causal mechanism between ADHD and
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characteristics of misuse, but limits this investigation to a preliminary assessment of the
predictive value of self-reported attention problems for the decision to misuse stimulant drugs. In
this study, personal and family history, current ADHD symptomatology, and past ADHD
symptomatology, which are all components of a clinical assessment of ADHD, will serve as
formative indicators for the latent variable called “ADHD symptomatology” (Figure 1). This
latent variable is meant to theoretically represent a preliminary assessment of ADHD symptoms
whereby scores on the formative indicators (personal and family history, current ADHD
symptomatology, past ADHD symptomatology) are the root cause for a participant’s outcomes
on the latent variables (ADHD symptomatology; Bollen & Diamantopoulos, 2015).
Another variable and uncertain characteristic of ADHD stimulant misuse is how it affects
academic performance. Studies have shown that students who misuse ADHD stimulants tend to
have lower GPA and poorer study habits compared to non-misusers (Ilieva & Farah, 2015;
Rabiner et al., 2010). However, the majority of misusers report a belief that their misuse of
ADHD stimulants improves their grades (Peterkin et al., 2011). While it is likely that these
variables are measuring different constructs, the results of these studies bring into question the
exact academic benefit of misuse. On the other hand, proper use of stimulants for persons with
ADHD is very strongly associated with an improved prognosis, with as much as 80% treatment
efficacy (Barkley, 2014). Additionally, there has been research suggesting some cognitive
benefit to stimulant medications even when someone does not have a diagnosis of ADHD
(Lakhan & Kirchgessner, 2012). If ADHD stimulant misuse represents self-treatment for
undiagnosed ADHD, then misusers may actually be deriving a cognitive benefit from misuse that
improves their academic performance.

6

Understanding the nature of any academic benefits of misuse is particularly important for
research because perceived academic benefit may be the major reason for misuse in the first
place. A large body of evidence shows that misusers report academic reasons as their primary
basis for misuse (Hartung et al., 2013; Peterkin et al., 2011; Rabiner et al., 2009; Teter et al.,
2005). Typically, these include “help concentrate,” “study for an exam,” or “improve grades.”
Other common motives for misuse include social reasons, such as “socialize better” and “get
energized,” and personal enhancement reasons, such as “get high” and “lose weight” (Hartung et
al., 2013; Peterkin et al., 2011; Rabiner et al., 2009; Teter et al., 2005). However, these
alternative motives have all been reported significantly less often than academic enhancement
reasons. Thus, there is a clear need to better understand how students perceive these stimulant
medications to be affecting them.
Substance abuse is also often assumed and studied in the context of ADHD stimulant
misuse, since prescription stimulants are considered Schedule II regulated drugs under the
Controlled Substances Act (CSA; Lakhan & Kirchgessner, 2012). Many studies have found that
misusers are more likely than non-misusers to experience problems with general substance abuse
(Hartung et al., 2013; Rabiner et al., 2010; Sepúlveda et al., 2011; Teter et al., 2005).
Additionally, a study conducted on those who distribute ADHD medications to misusers found
that distributors are also more likely to experience substance abuse problems compared to nondistributors (DeSantis, Anthony, & Cohen, 2013). Rabiner et al. (2010) also found that substance
abuse was a significant predictor of new incidents of ADHD stimulant misuse. Thus, substance
abuse, as well as problems typically associated with it, may mediate the predictive value of
ADHD symptomatology on stimulant medication misuse.
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CHAPTER III
THE CURRENT STUDY
While many studies have been conducted that describe the characteristics of misusers,
few have attempted to predict the frequency of ADHD stimulant misuse using these
characteristics. The purpose of the current study is to identify the predictive value ADHD
symptomatology has on several characteristics of ADHD stimulant misuse. This will be assessed
using an online survey incorporating several validated measures. We hypothesize that as ADHD
symptomatology increases, the frequency of ADHD stimulant misuse will also increase. This
relationship will occur both directly and indirectly through academic motives of misuse and
substance abuse problems mediators (Figure 1).
We propose that an undergraduate student suffering from unexplained problems with
inattention and impulsivity would desire to find an easy solution for overcoming these problems.
ADHD stimulant misuse may be perceived as one such simple solution. Additionally, students
experiencing these problems will likely encounter academic difficulties as well. This would
likely motivate them to address these problems and find a solution to improve their academic
performance. ADHD stimulant misuse could be viewed as a solution to these academic
difficulties. Finally, a student with undiagnosed ADHD symptoms may already be impulsively
turning to substance abuse and be experiencing consequences associated with substance abuse.
This may explain why such a student would turn to an illegal behavior as a solution to their
academic problems.
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CHAPTER IV
METHOD
PARTICIPANTS
A total of 1,082 students from a large university in southeastern Virginia completed the
survey. Among these participants, 206 (19.04%) indicated that they had misused ADHD
stimulants over the past six months. Twenty-two misusers were removed from analysis because
they either were not undergraduate students, did not complete the survey as instructed, or had
outliers, leaving 184 misusers for the final analyses. The mean age of the misusers was 22.31
years (SD = 5.55). The majority of misusers was female (65.80%), Caucasian (62.50%), and in
their senior year of undergraduate studies (31.00%).
MEASURES
ADHD stimulant misuse. One question separated participants into two groups.
Answering “Yes” to the question “During the past 6 months, have you ever taken an ADHD
stimulant medication (ex: Ritalin, Adderall, Concerta, Focalin, Vyvanse) without having a
prescription for that medication or in a manner not recommended by the prescription's
instructions (ex: taking more pills than suggested, taking pills at times not suggested)?” placed
participants into the “Misuser” group. Answering “No” to this question placed participants into
the “Non-Misuser” group.
Participants in the misuser group were asked seven questions regarding characteristics of
their misuse (Appendix A). These included the name and dosage of their most often used
stimulant, whether or not they were currently prescribed the stimulant, the frequency of misuse
over the past six months, how they perceived the misuse had affected their grades, and the time
of the day and day of the week they most often misuse stimulants. The dosage question also
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served as an attention check as participants must write “Don’t know” if they did not know the
dosage of their most often used stimulant.
Non-misuser participants were asked four questions regarding their knowledge of ADHD
stimulant misuse (Appendix B). These included their awareness of misuse and whether they
personally knew anyone who has misused or has distributed stimulant medications to other
students. Additionally, non-misusers were asked to list any drug, medication, or substance they
had used in the past six months for the purpose of academic improvement. This question was
designed to catch any false negatives who may not have realized they were engaging in ADHD
stimulant misuse. Additionally, this question served as an attention check as participants must
write “N/A” if they have not used any substances for academic improvement in the past six
months.
ADHD symptomatology. Three sets of questions were asked to determine the severity of
ADHD symptomatology among participants.
Personal and family history. Four questions were asked regarding current and past
diagnoses of ADHD, as well as a family history of ADHD. These included if the participant was
ever diagnosed with ADHD by a healthcare professional, if the participant was currently
diagnosed with ADHD, and whether their biological parents and siblings were ever diagnosed
with ADHD. These were all yes or no questions.
Current symptomatology. The six screening questions from the WHO ASRS were used
to assess current ADHD symptom severity (Appendix C). These six questions had the highest
sensitivity (68.7%) and specificity (99.5%) of all the questions in the ASRS (Kessler et al.,
2007). An example question from this scale was “How often do you have problems remembering
appointments or obligations?” These questions were measured on a 5-point Likert scale ranging
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from 1 (Never) to 5 (Very Often). The Cronbach’s alpha for this scale was .63-.72. This was
expected to be low because the methods used to develop the scale intentionally selected the least
number of questions possible to capture the symptoms on two different dimensions: inattention
and hyperactivity (Kessler et al., 2007). Test-retest reliability was found to be between .58-.77.
Predictive validity, measured as the screener’s ability to predict new cases of adult ADHD
diagnosed by clinicians who did not use the scale, was .82 (Kessler et al., 2007).
Past symptomatology. Twenty-five questions from the Wender Utah Rating Scale
(WURS) were used to measure past ADHD symptom severity (Appendix D). This was important
to measure because proper clinical assessment of ADHD in adults is significantly improved by
investigating symptoms retrospectively (Ward, Wender, & Reimherr, 1993). An example
question from this scale was “As a child, I was (or had): concentration problems, easily
distracted.” These questions were measured on a 5-point Likert scale ranging from 1 (Not at all)
to 5 (Very much). Cronbach’s alpha for this measure was .78-.91. Split-half reliability was found
to be .9. Convergent validity, as measured by correlating the scores from the WURS to scores
from the Conners Abbreviated Rating Scale, a short measure of childhood ADHD symptoms,
was .41-.49 (Ward et al., 1993).
Academic motives of misuse. The six cognitive enhancement questions from the
Caffeine Motives Questionnaire (CMQ-CE) were used to assess academic motives for ADHD
stimulant misuse (Appendix E; Irons et al., 2014). This questionnaire was selected because the
motives represented by these questions were analogous to the academic motives assessed in
previous ADHD stimulant misuse research (Hartung et al., 2013; Peterkin et al., 2011; Rabiner et
al., 2009; Teter et al., 2005). An example motive from the CMQ-CE was “to feel more alert.”
These questions were measured on a 5-point Likert scale ranging from 1 (Never) to 5 (Almost
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always). Cronbach’s alpha for the CMQ-CE was .92. Construct validity, measured as the
correlation between CMQ-CE and frequency of caffeine consumption, was .2-.25. Discriminant
validity, measured as the correlation between CMQ-CE and the three other motives used in the
full CMQ (negative affect relief, reinforcing effects, and weight control), was .26-.58 (Irons et
al., 2014).
Substance abuse problems. The Drug Abuse Screening Test, 10-item version (DAST10) was used to assess problems with general substance abuse, excluding the use of ADHD
stimulants (Appendix F). This was a short measure that has been shown to accurately capture
substance abuse problems in diverse populations, including patients with ADHD (Yudko,
Lozhkina, & Fouts, 2007). An example question from the DAST-10 was “Have you used drugs
other than those required for medical reasons?” All of these were yes or no questions. The
Cronbach’s alpha for the DAST-10 was .86-.94. Concurrent validity, measured as the correlation
between the DAST-10 and the longer DAST-20, was .97. Construct validity, measured as the
correlation between the DAST-10 and the Addiction Severity Index, was .31-.4 (Yudko et al.,
2007).
Demographics. Four demographic questions were included regarding the participants’
age, gender, year in school, and race.
PROCEDURE
The online survey was developed using Qualtrics. After obtaining approval from the
ODU IRB, an announcement webpage was created that included the link to the survey
(Appendix G). This webpage was posted on the university’s announcements website and a link
to the webpage was incorporated into the university’s student announcements email. This email
was sent to all students every day around 12:20 am. A statement was included on the webpage
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asking undergraduate students to participate in a study investigating college ADHD stimulant
use. The webpage was posted for several weeks of the Fall 2016 semester. For the remaining few
weeks of the Fall 2016 semester, participants were recruited through the university’s psychology
research participation system.
Before beginning the survey, participants read a consent form asking if they consented to
participate in the study (Appendix H). To maintain anonymity, online signatures were not
obtained. After consenting and completing the survey, participants were debriefed, provided with
substance abuse and ADHD resources, and encouraged to leave any comments regarding the
study (Appendix I). Upon completion of the survey, participants recruited through the
announcements webpage were redirected to a separate survey where they could enter into a raffle
to win a $50 Amazon gift card. This raffle was run by a third party unaffiliated with the current
study. Information collected by this third party were never shared with the researcher.
Participants recruited through the research participation system were granted 0.5 psychology
research credits upon completion of the survey.
ANALYSIS
The strength of the predictions within the proposed model was assessed using structural
equation modeling (SEM). For each scale, a total score was produced by adding the assigned
point values for each of the selected responses together. Total score on the DAST-10 was the
operationalization for substance abuse problems. The total score for the CMQ-CE was used to
represent academic motives for misuse. For the ADHD symptomatology latent variable, the total
scores on the WHO ASRS, WURS, and personal and family history questions were loaded as
formative indicators. Models that either had perfect fit or a non-significant χ2, root mean square
error of approximation (RMSEA) of < .1, comparative fit index (CFI) > .90, and standardized
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root mean square residual (SRMR) < .05 were considered to have adequate fit (Hooper,
Coughlan, & Mullen, 2008).
Power analysis and sample size determination for SEM are difficult to apply. Currently,
there are three generally accepted power analysis methods, and each one typically gives a
different minimum sample size using similar variables as the others (MacCallum, Browne, &
Sugawara, 1996; Muthén & Muthén, 2002; Satorra & Saris, 1985). Additionally, researchers
using SEM have been known to cite general rules-of-thumb as their estimate of sample size
(Wolf, Harrington, Clark, & Miller, 2013). A study by Wolf and colleagues (2013) assessed the
utility of each of these approaches. They not only found that each method produced a different
minimum sample size needed to meet desired power, but also that the results fluctuated with
varying characteristics of the models, such as bias and missing data. As such, the authors
concluded that power analysis or rules-of-thumb alone are not enough to determine desired
sample size for a study using SEM. They instead suggested determining sample size by
accounting for the unique characteristics of the model and the study’s design in addition to a
valid sample size estimation technique (Wolf et al., 2013).
Following these suggestions by Wolf et al. (2013), the current study sought a minimum
misuser sample size with desired power at .8 and alpha at .05, and found the minimum sample
size to be 90. This agrees with estimates for models using latent variables (Muthén & Muthén,
2002; Wolf et al., 2013), as well as an accepted SEM rule-of-thumb ratio of 20 participants per
variable (Tanaka, 1987). Additionally, this is a close estimate to the percentage of misusers
obtained in more recent surveys of undergraduate populations (Hartung et al., 2013; Ilieva &
Farah, 2015).
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CHAPTER V
RESULTS
INTERNAL CONSISTENCY
Cronbach’s alpha was used to determine the internal consistency of the scales used. The
WURS (α = .944), CMQ-CE (α = .854), and the personal and family history measure (α = .713)
all displayed good internal consistency. The ASRS (α = .603) had relatively low internal
consistency. However, this was not considered problematic as this level of Cronbach’s alpha was
expected to occur for this scale and is in agreement with results from its validation study (Kessler
et al., 2007). The DAST-10 (α = .644) was also found to have relatively low internal consistency.
This was considered problematic, and the implications of this are described in the Discussion.
NON-MISUSER CHARACTERISTICS
The majority of non-misusers in this sample were aware that ADHD stimulant misuse
was occurring (76.70%; Table 1). Most non-misusers also personally knew someone who had
misused ADHD stimulants in the past (52.50%). Most non-misusers did not personally know
someone who had distributed ADHD stimulants though (59.60%). Finally, six students (0.74%)
indicated they were using ADHD stimulants for the purposes of academic improvement despite
indicating that they were not a misuser and did not currently have a prescription for stimulant
medication. It is possible that these false negatives did not consider what they were doing as
ADHD stimulant misuse.
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Table 1
Non-Misuser Characteristics
Characteristic
Know ADHD Stimulant Misuse
Yes
No
Missing
Know Misuser
Yes
No
Missing
Know Distributor
Yes
No
Missing
Note. N = 810

Frequency (%)
621 (76.70)
186 (23.00)
3 (0.40)
425 (52.50)
331 (40.90)
54 (6.70)
280 (34.60)
483 (59.60)
47 (5.80)

MISUSER CHARACTERISTICS
Misusers were described in this study as someone who either obtained and used a
stimulant without having a prescription for it or someone who used their currently prescribed
stimulant in a manner that deviates from the prescription’s instructions (e.g. taking more pills
than suggested, taking pills at times not suggested). The majority of misusers in this sample
belonged to the former category (72.30%; Table 2). The most commonly misused stimulant was
Adderall (68.50%). The mean number of incidents of misuse over the past six months was 3.56
(SD = 2.55). On average, misusers indicated that their misuse was only slightly improving their
grades (M = 3.55, SD = 0.78). Most misusers were taking the stimulants on Mondays (25.00%)
and in the morning (41.30%). According to the Physicians’ Desk Reference (PDR, 2017), most
misusers seemed to take an appropriate dosage of their indicated medication (85.05%). It should
be noted, however, that decisions regarding appropriate dosage relate to symptom intensity, body
weight, side effect tolerance, and actual effects of the medication and can only be made by a
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licensed health care professional (PDR, 2017). Thus, we cannot be certain whether or not an
appropriate dosage was taken by misusers in this study.

Table 2
Misuser Characteristics
Characteristic
Type of Misuse
Prescribed
Non-Prescribed
Stimulant Misused
Ritalin
Adderall
Concerta
Focalin
Vyvanse
Intuniv *
Methylphenidate*
Missing
Effect on Grades
Significantly decreased
Decreased
Neither decreased nor increased
Increased
Significantly increased
Missing
Time of Day for Misuse
Morning
Afternoon
Evening
Missing
Day of Week for Misuse
Monday
Tuesday
Wednesday
Thursday
Friday
Saturday
Sunday
Missing
Note. N = 184; *Write-in answers for “Other” option.

Frequency (%)
51 (27.70)
133 (72.30)
9 (5.30)
126 (68.50)
6 (3.30)
1 (0.50)
27 (14.70)
1 (0.55)
1 (0.55)
13 (7.10)
3 (1.60)
5 (2.70)
74 (40.20)
73 (39.70)
16 (8.70)
13 (7.10)
76 (41.30)
43 (23.40)
53 (28.80)
12 (6.50)
46 (25.00)
23 (12.50)
27 (14.70)
18 (9.80)
24 (13.00)
13 (7.10)
13 (7.10)
20 (10.90)
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SEM ANALYSIS
For all SEM analysis, missing data was handled using maximum likelihood (ML)
estimation (Messer & Natarajan, 2008). Bootstrapping was used to reduce the impact of nonnormality (Preacher & Hayes, 2004). All results were estimated using STDYX estimation.
Means, standard deviations (SDs), and bivariate correlations for all predictor, outcome, and
demographic variables can be found in Table 3. Because age was found to significantly correlate
with frequency of misuse, age was added as a covariate to all models that predicted frequency of
misuse.

Table 3
Mean, SDs, and Correlations between Predictor, Outcome, and Demographic Variables
Variable
1
2
3
4
5
6
7
8
9
10
11
1
1. ADHD symptomatology
- .19* .19* .21* .45** .62** .99** .15 -.01 -.01
.03
2. Academic motives of misuse
- .18* .19* -.02 .11
.12* -.10 .12
-.01 .04
3. Substance abuse problems
.16 -.04 .11
.21** .15 -.07
.02
.02
4. Frequency of misuse
.25** .25** .20* .21* -.07 .08
.10
5. Personal and family history
- .25** .40** .22** -.13 -.09 .10
6. Current symptomatology
.58** .14 -.04 .02 .04
7. Past symptomatology
.13
.01 .01 .03
8. Age
-.03 .41** .10
9. Gender
- .17* -.02
10. Year in school
- -.01
11. Race
Mean
57.70 18.51 2.95 3.56 1.20 14.05 42.41 22.31 SD
22.49 5.46 1.86 2.55 1.34 3.53 21.00 5.55 Min
0
6
0
1
0
0
0
18
Max
109 30
9
12
4
30
100
50
Note. 1- Measured as a composite variable. * p < .05 ** p < .001

A confirmatory factor analysis (CFA) was first run to determine the factor loadings (b*)
of personal and family history, current symptomatology, and past symptomatology on the ADHD
symptomatology latent variable. This model was found to have perfect fit. However, while past
symptomatology was found to strongly load onto the latent variable, personal and family history
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as well as current symptomatology did not strongly load onto the latent variable (Table 4).
Therefore, ADHD symptomatology was not considered a latent variable for the remainder of the
analysis. Instead, the total scores of the personal and family history questions, ASRS, and WURS
were added together to form an aggregate construct, whereby a composite variable is created to
represent the cumulative effects of each variable contributing to the construct (Edwards, 2001).

Table 4
Factor Loadings onto ADHD Symptomatology Latent Variable
Index
b*
SE
Personal and family history
.42
.08
Current symptomatology
.60
.08
Past symptomatology
.97
.11

p
.001
.001
.001

95% CI
[0.27, 0.57]
[0.44, 0.76]
[0.76, 1.19]

To determine the strength of the proposed model when treating all variables as composite
scores, a path analysis, bootstrapping with 10,000 replications, was run on the full model (Figure
2). The full model was found to have perfect fit. All path coefficients (b*) can be seen in Table 5.
There were significant direct effects between ADHD symptomatology and frequency of misuse
(b* = .18, p = .050, R2 = .14), academic motives of misuse (b* = .19, p = .009, R2 = .05), and
substance abuse problems (b* = .19, p = .015, R2 = .06). There was also a significant direct effect
between academic motives of misuse and frequency of misuse (b* = .17, p = .032). However,
there was not a significant direct effect between substance abuse problems and frequency of
misuse (b* = .06, p = .623). Additionally, there was a marginally significant indirect effect
between ADHD symptomatology and frequency of misuse via academic motives of misuse (b* =
.04, p = .054) and no significant indirect effect via substance abuse problems (b* = .01, p =
.817).
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Academic Motives
of Misuse
.17*

.19*

ADHD
Symptomatology

Frequency of
Misuse

.18*

.19*

.06

Substance
Abuse Problems

Figure 2. Standardized path coefficients for full model. Significance is based off bootstrapped
CI. * indicates that 95% CI does not include 0. Although not graphically represented, age was
included as a significant covariate.

Table 5
Direct and Indirect Effects for the Full Model
Pathway
b*
Direct effect between frequency of misuse and
ADHD symptomatology
.18
Academic motives of misuse
.17
Substance abuse problems
.06
Direct effect between ADHD symptomatology and
Academic motives of misuse
.19
Substance abuse problems
.19
Indirect effect via
Academic motives of misuse
.04
Substance abuse problems
.01
Note. Age was included as a significant covariate in this model.

SE

p

95% CI

.01
.03
.15

.050
.032
.623

[0.01, 0.04]
[0.01, 0.14]
[-0.22, 0.38]

.02
.01

.009
.015

[0.01, 0.09]
[0.01, 0.03]

.02
.02

.054
.817

[-0.01, 0.09]
[-0.04, 0.05]
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Because the DAST-10 displayed low internal consistency within this sample, the
substance abuse problems variable was removed from the model and the path analysis,
bootstrapping with 10,000 replications, was re-run (Figure 3). This model was also found to have
perfect fit. Significant direct effects were again found between ADHD symptomatology and
frequency of misuse (b* = .19, p = .037, R2 = .14) as well as between ADHD symptomatology
and academic motives of misuse (b* = .19, p = .009, R2 = .06). There was also a significant direct
effect between academic motives of misuse and frequency of misuse (b* = .18, p = .026).
Finally, the indirect effect between ADHD symptomatology and frequency of misuse via
academic motives of misuse was significant (b* = .05, p = .048; see Table 6).

Academic Motives
of Misuse
.18*

.19*

ADHD
Symptomatology

.19*

Frequency of
Misuse

Figure 3. Standardized path coefficients for model without substance abuse problems.
Significance is based off bootstrapped CI. * indicates that 95% CI does not include 0. Although
not graphically represented, age was included in the model as a significant covariate.
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Table 6
Direct and Indirect Effects for the Model Without Substance Abuse Problems
Pathway
b*
SE
p
Direct effect between frequency of misuse and
ADHD symptomatology
.19
.01
.037
Academic motives of misuse
.18
.03
.026
Direct effect between ADHD symptomatology and
Academic motives of misuse
.19
.02
.009
Indirect effect via
Academic motives of misuse
.05
.02
.048
Note. Age was included as a significant covariate in this model.

95% CI
[0.01, 0.04]
[0.01, 0.14]
[0.01, 0.09]
[0.01, 0.09]

As an exploratory analysis, the model in Figure 2 was re-tested using only misusers who
were not prescribed their most often misused stimulant (N = 133). This was run because it is
theoretically possible that problems related to substance abuse are more likely to arise in nonprescribed misusers, as their act of misuse more similar to constructs of substance abuse
problems compared to prescribed misusers (Yudko et al., 2007). The path analysis was re-run,
bootstrapping with 10,000 replications. This model was found to have perfect fit. However, the
direct effect between substance abuse problems and frequency of misuse remained nonsignificant (b* = .18, p = .16, R2 = .05). Additionally, the indirect effect of ADHD
symptomatology and frequency of misuse via substance abuse problems also remained nonsignificant (b* = .03, p = .24).
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CHAPTER VI
DISCUSSION
The purpose of this study was to determine the predictive value of ADHD
symptomatology on the frequency and characteristics of ADHD stimulant misuse. Results from
the path analyses revealed that ADHD symptomatology significantly predicted frequency of
ADHD stimulant misuse. Based on these findings, an undergraduate student with higher ADHD
symptom severity is at particular risk for misusing ADHD stimulants more often. This provides
support to the notion that ADHD stimulant misuse may represent a form of self-treatment for
undiagnosed or under-treated ADHD (Hartung et al., 2013; Peterkin et al., 2011; Rabiner et al.,
2009). Additionally, academic motives for misuse were also found to significantly predict
frequency of ADHD stimulant misuse. Finally, a significant mediation effect of ADHD
symptomatology on frequency of ADHD stimulant misuse via academic motives for misuse was
found. Taking the whole model into account, the results seem to support the notion that a student
experiencing unexplained problems such as difficulty concentrating on finishing assignments or
staying awake or alert to study for a test would turn to stimulant misuse as a potential solution.
To help determine whether this behavior might be seen by treatment providers as an adaptive or
maladaptive self-assessment and self-treatment strategy, a follow-up to this study might identify
to what degree misusers actually have untreated ADHD by having misusers undergo a formal
clinical assessment for ADHD. It is especially important to use a formal clinical assessment for
ADHD because this is what the ADHD symptomatology latent variable was meant to represent
in the current study. As the CFA showed poor factor loadings on this latent variable, it may be
best if future studies use a formal clinical assessment rather than latent variable analysis to study
the effects of ADHD on stimulant misuse.
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It was also hypothesized that a misuser might already be impulsively turning to substance
abuse and experiencing associated problems from it, perhaps revealing the misuser’s attempt to
justify another form of substance abuse to help solve academic difficulties. However, this
hypothesis was not supported by this study’s data. Possible explanations for the failure of this
hypothesis to be borne out by the data include, first, that there were problems discovered with the
reliability of the substance abuse measure. However, this does not likely represent a problem
with the DAST-10, which has been found to be a highly valid and reliable measure in past
research (Yudko et al., 2007). Second, this study may have been underpowered for detecting the
hypothesis, a notion discussed below in greater detail. Third, independent substance abuse
problems may simply have little predictive value on frequency of misuse. While prior studies
using the DAST-10 found that the majority of ADHD stimulant misusers reported significant
substance abuse associated problems (McCabe & Teter, 2007; Sepúlveda et al., 2011), these
studies did not use predictive models in their research design. Thus, a question has been raised
regarding which behavior, stimulant misuse or substance abuse problems, preceded the other
(Sepúlveda et al., 2011). A study conducted by Arria et al. (2012) found that a positive
assessment of either cannabis use disorder or alcohol use disorder did significantly predict
ADHD stimulant misuse. Since problems associated with substance abuse are likely to occur
after the development of a substance use disorder, ADHD stimulant misuse may precede
substance abuse problems. Thus, in theory, a student who is using other mind altering substances
such as alcohol or cannabis and is experiencing academic difficulties due to unexplained
problems with attention and impulsivity may turn to another substance, an ADHD stimulant, for
solutions. In the long term, this form of polysubstance use may lead to medical, social, and
family problems. Future studies could develop a predictive model that tests this hypothesis.
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Future studies could also examine other factors that may predict frequency of misuse.
Since the effect sizes found in this current study were relatively small, there are several apt to be
other variables not examined here that could also contribute to a student’s desire to misuse
ADHD stimulants. For example, this study identified age as a variable that showed a trend in this
regard, such that older students tended to misuse ADHD stimulants more often. Other factors
that are known correlates with both ADHD and substance abuse, such as antisocial behavior
(Mannuzza, Klein, & Moulton, 2008; Van Eck, Markle, & Flory, 2012) and low
conscientiousness (Lackner, Unterrainer, & Neubauer, 2013; Nigg et al., 2002), may also play
mediating roles in the relationship between ADHD symptomatology and frequency of misuse.
Future studies might investigate such potential intervening motives as misusers’ disinclination to
seek medical treatment for possible ADHD symptoms as predictors of misuse among students
with both attention and academic difficulties.
Several other inferences and future research ideas can be drawn from the misuser and
non-misuser characteristics. Data from the non-misusers show that ADHD stimulant misuse is
well-known to many students and relatively common on undergraduate campuses. Thus, there is
a need to develop targeted interventions that address reasons and preventative strategies for
stimulant misuse, particularly for the misusers who are using stimulants without a prescription.
Under the CSA, this is considered an illicit act (Lakhan & Kirchgessner, 2012). Additionally,
ADHD stimulants may cause detrimental cardiovascular side-effects and at particularly high
dose levels have addictive potential (PDR, 2017). Therefore, finding alternative methods for
addressing academic difficulties in these students, perhaps with new study techniques or
assessments by medical professionals to obtain stimulants in a controlled manner, is crucial.
Another finding of interest from this study was that misusers most often took the stimulants on
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Monday mornings. Given findings here and previously that academic reasons motivates ADHD
stimulant misuse (Hartung et al., 2013; Peterkin et al., 2011; Rabiner et al., 2009; Teter et al.,
2005), Monday mornings may represent important or key times for optimal academic
performance. Future studies could further investigate when and why ADHD stimulants are
misused in order to reach these students with alternatives to misuse. Finally, misusers reported
slight grade improvement from misuse, in agreement with previous work (Peterkin et al., 2011).
However, there has still been no study of the precise effects ADHD stimulant misuse has on
grades. Research models tested by Arria and colleagues (2012) did include GPA changes in data
gathered, but these data were used to predict incidents of ADHD stimulant misuse. Studying
objective (rather than self-report) effects of ADHD stimulant misuse on grades is an important
area of inquiry because ADHD stimulants seem to produce cognitive benefits for those with and
without an ADHD diagnosis (Barkley, 2014; Lakhan & Kirchgessner, 2012).
LIMITATIONS
One of the more pressing limitations of this study is that it might be underpowered for
detecting some hypotheses. As previously discussed, power analysis and sample size
determination for SEM studies can use a variety of methods that generate different results under
similar parameters (MacCallum et al., 1996; Muthén & Muthén, 2002; Satorra & Saris, 1985).
This study adapted guidelines described by Wolf et al. (2013) to determine a needed sample size
of 90 misusers. However, Fritz and MacKinnon (2007) described a post-hoc power analysis
technique to assess if adequate power was achieved in mediation models. Using their approach,
this study required a very broad range of 78 to 558 misusers to achieve adequate power. While
the current study’s sample size fits within the lower end of that range, the extent of the range
suggests that the sample size may have been problematic. To make this analysis still more
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uncertain, Loeys, Moerkerke, and Vansteelandt (2014) argue that in studies that test for indirect
effects, such as the current study, the Fritz and MacKinnon (2007) method may not always be
reliable. Nevertheless, power may have been a concern that should be addressed by future
research with larger samples of misusers to avoid weak statistical power and both falsely
significant and falsely non-significant results (Maxwell, 2004).
A second limitation of the current study is the low internal consistency found for the
DAST-10. While the notion that Cronbach’s alpha must be greater than .7 to be considered
reliable has been refuted (Lance, Butts, & Michels, 2006), the internal consistency found in this
study was noticeably lower than those in previous studies that utilized the DAST-10 (McCabe &
Teter, 2007; Yudko et al., 2007). Again, the most likely explanation is that the current study was
underpowered. However, it should also be noted that the DAST-10 has never been validated
within a population of ADHD stimulant misusers. Should adequately-powered follow-up studies
also experience internal consistency problems with the DAST-10, it may mean that the
constructs represented by this measure are not prevalent among ADHD stimulant misusers. This
would mean that studies would be needed to verify that substance abuse problems as measured
by the DAST-10 are experienced by ADHD stimulant misusers similarly to other forms of
substance abuse.
A final noteworthy limitation of this study was the method for determining frequency of
misuse. In the survey, participants were given a blank space to freely input how often they
misused ADHD stimulants over the past six months. Unfortunately, many participants gave
uninterpretable answers, such that data for this variable was considered “missing” for many
participants. While this problem was corrected for by ML estimation, the study’s findings would
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be significantly more accurate if participants had been prompted to enter a single number to
describe their frequency of misuse.
CONCLUSIONS
In this study, ADHD symptomatology did seem to predict frequency of ADHD stimulant
misuse and, as predicted, this effect was mediated by academic motives for misuse. Thus,
undergraduate students experiencing dual problems with inattention/hyperactivity and academic
difficulties might turn to ADHD stimulant misuse as a solution. As ADHD stimulant misuse is
considered an illicit behavior, has associated health problems, and its effects on academic
performance are not currently well understood, this may be a poor solution. Though previous
research clearly shows that substance abuse plays a role in ADHD stimulant misuse, problems
associated with substance abuse may occur in response to stimulant misuse alongside other
forms of substance abuse. Age and other variables not analyzed in this study may also play
mediating roles in ADHD stimulant misuse. Follow-up studies are crucial to continued efforts to
delineate the motives and outcomes of what appears to be common and well-known ADHD
stimulant misuse among college students seeking help for attention-related academic problems.
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APPENDIX A
MISUSER QUESTIONS
During the past 6 months, which one of the following ADHD stimulant medications have you
used the most frequently without having a prescription for it or in a manner not recommended by
the prescription's instructions (ex: taking more pills than suggested, taking pills at times not
suggested)?
 Ritalin
 Adderall
 Concerta
 Focalin
 Vyvanse
 Other ____________________
What is the dosage of the medication indicated above that you most often use? If you do not
know, please write "don't know"
(Open ended response)
What time of day during the past 6 months do you typically use ADHD stimulant medications
without having a prescription for it or in a manner not recommended by the prescription's
instructions (ex: taking more pills than suggested, taking pills at times not suggested)?
 Morning
 Afternoon
 Evening
Which day of the week during the past 6 months do you typically use ADHD stimulant
medications without having a prescription for it or in a manner not recommended by the
prescription's instructions (ex: taking more pills than suggested, taking pills at times not
suggested)?
 Monday
 Tuesday
 Wednesday
 Thursday
 Friday
 Saturday
 Sunday
During the past 6 months, approximately how many times have you used any ADHD stimulant
medication without having a prescription for it or in a manner not recommended by the
prescription's instructions (ex: taking more pills than suggested, taking pills at times not
suggested)?
(Open ended response)
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During the past 6 months, how has taking ADHD stimulant medications (ex: Ritalin, Adderall,
Concerta, Focalin, Vyvanse) without having a prescription for that medication or in a manner not
recommended by the prescription's instructions (ex: taking more pills than suggested, taking pills
at times not suggested) affected your grades?
 Significantly decreased
 Decreased
 Neither decreased nor increased
 Increased
 Significantly increased
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APPENDIX B
NON-MISUSER QUESTIONS
In undergraduate colleges across the United States, it has been reported that some students use
ADHD stimulant medications without having a prescription for them or in a manner not
recommended by the prescription instructions.
Were you aware of this trend before enrolling in this study?
 Yes
 No
Do you personally know anyone who has engaged in this activity?
 Yes
 No
 Don't know
Do you personally know anyone who has distributed their prescription ADHD stimulant
medication to other students who do not have a prescription for them?
 Yes
 No
 Don't know
Please list any drug, medication, or substance you have used in the past 6 months for the purpose
of academic improvement. If you have not used any, please write "N/A"
(Open ended response)
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APPENDIX C
ADULT ADHD SELF-REPORT SCALE
Please answer the questions below, rating yourself on each of the criteria shown using the
provided scale. As you answer each question, select the response that best describes how
you have felt and conducted yourself over the past 6 months.
1. How often do you have trouble wrapping up the final details of a project, once the challenging
parts have been done?
1. Never
2. Rarely
3. Sometimes
4. Often
5. Very Often
2. How often do you have difficulty getting things in order when you have to do a task that
requires organization?
1. Never
2. Rarely
3. Sometimes
4. Often
5. Very Often
3. How often do you have problems remembering appointments or obligations?
1. Never
2. Rarely
3. Sometimes
4. Often
5. Very Often
4. When you have a task that requires a lot of thought, how often do you avoid or delay getting
started?
1. Never
2. Rarely
3. Sometimes
4. Often
5. Very Often
5. How often do you fidget or squirm with your hands or feet when you have to sit down for a
long time?
1. Never
2. Rarely
3. Sometimes
4. Often
5. Very Often

37

6. How often do you feel overly active and compelled to do things, like you were driven by a
motor?
1. Never
2. Rarely
3. Sometimes
4. Often
5. Very Often
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APPENDIX D
WENDER-UTAH RATING SCALE
As a child, I was (or had):
1. Concentration problems, easily distracted
1. Not at all
2. Mildly
3. Moderately
4. Quite a bit
5. Very much
2. Anxious, worrying
1. Not at all
2. Mildly
3. Moderately
4. Quite a bit
5. Very much
3. Nervous, fidgety
1. Not at all
2. Mildly
3. Moderately
4. Quite a bit
5. Very much
4. Inattentive, daydreaming
1. Not at all
2. Mildly
3. Moderately
4. Quite a bit
5. Very much
5. Hot- or short-tempered, low boiling point
1. Not at all
2. Mildly
3. Moderately
4. Quite a bit
5. Very much
6. Temper outbursts, tantrums
1. Not at all
2. Mildly
3. Moderately
4. Quite a bit
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5. Very much
7. Trouble with stick-to-it-tiveness, not following through, failing to finish things started
1. Not at all
2. Mildly
3. Moderately
4. Quite a bit
5. Very much
8. Stubborn, strong-willed
1. Not at all
2. Mildly
3. Moderately
4. Quite a bit
5. Very much
9. Sad or blue, depressed, unhappy
1. Not at all
2. Mildly
3. Moderately
4. Quite a bit
5. Very much
10. Disobedient with parents, rebellious, sassy
1. Not at all
2. Mildly
3. Moderately
4. Quite a bit
5. Very much
11. Low opinion of myself
1. Not at all
2. Mildly
3. Moderately
4. Quite a bit
5. Very much
12. Irritable
1. Not at all
2. Mildly
3. Moderately
4. Quite a bit
5. Very much
13. Moody, ups and downs
1. Not at all
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2. Mildly
3. Moderately
4. Quite a bit
5. Very much
14. Angry
1. Not at all
2. Mildly
3. Moderately
4. Quite a bit
5. Very much
15. Acting without thinking, impulsive
1. Not at all
2. Mildly
3. Moderately
4. Quite a bit
5. Very much
16. Tendency to be immature
1. Not at all
2. Mildly
3. Moderately
4. Quite a bit
5. Very much
17. Guilty feelings, regretful
1. Not at all
2. Mildly
3. Moderately
4. Quite a bit
5. Very much
18. Losing control of myself
1. Not at all
2. Mildly
3. Moderately
4. Quite a bit
5. Very much
19. Tendency to be or act irrational
1. Not at all
2. Mildly
3. Moderately
4. Quite a bit
5. Very much
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20. Unpopular with other children, didn’t keep friends for long, didn’t get along with other
children
1. Not at all
2. Mildly
3. Moderately
4. Quite a bit
5. Very much
21. Trouble seeing things from someone else’s point of view
1. Not at all
2. Mildly
3. Moderately
4. Quite a bit
5. Very much
22. Trouble with authorities, troubles with school, visits to principal’s office
1. Not at all
2. Mildly
3. Moderately
4. Quite a bit
5. Very much
23. Overall a poor student, slow learner
1. Not at all
2. Mildly
3. Moderately
4. Quite a bit
5. Very much
24. Trouble with mathematics or numbers
1. Not at all
2. Mildly
3. Moderately
4. Quite a bit
5. Very much
25. Not achieving up to potential
1. Not at all
2. Mildly
3. Moderately
4. Quite a bit
5. Very much
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APPENDIX E
CAFFEINE MOTIVES QUESTIONNAIRE, COGNITIVE ENHANCEMENT
I choose to take ADHD stimulant medication (ex: Ritalin, Adderall, Concerta, Focalin,
Vyvanse) without having a prescription for that medication or in a manner not
recommended by the prescription's instructions…
1. To feel more alert
1. Never
2. Rarely
3. Sometimes
4. Often
5. Almost always
2. To help me concentrate
1. Never
2. Rarely
3. Sometimes
4. Often
5. Almost always
3. To combat drowsiness
1. Never
2. Rarely
3. Sometimes
4. Often
5. Almost always
4. To help me focus my attention
1. Never
2. Rarely
3. Sometimes
4. Often
5. Almost always
5. Because I like the “jolt” of energy rush I feel
1. Never
2. Rarely
3. Sometimes
4. Often
5. Almost always
6. To stay awake
1. Never
2. Rarely
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3. Sometimes
4. Often
5. Almost always
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APPENDIX F
DRUG ABUSE SCREENING TEST, 10-ITEM VERSION
Answer the following questions regarding your behavior over the past 6 months excluding
any use of ADHD stimulants (ex: Ritalin, Adderall, Concerta, Focalin, Vyvanse)
1. Have you used drugs other than those required for medical reasons?
1. Yes
2. No
2. Do you abuse more than one drug at a time?
1. Yes
2. No
3. Are you always able to stop using drugs when you want to? (If never used drugs, answer Yes)
1. Yes
2. No
4. Have you had "blackouts" or "flashbacks" as a result of drug use?
1. Yes
2. No
5. Do you ever feel bad or guilty about your drug use? (If never used drugs, answer No)
1. Yes
2. No
6. Does your spouse or parents ever complain about your involvement with drugs?
1. Yes
2. No
7. Have you neglected your family because of your use of drugs?
1. Yes
2. No
8. Have you engaged in illegal activities in order to obtain drugs?
1. Yes
2. No
9. Have you ever experienced withdrawal symptoms (felt sick) when you stopped taking drugs?
1. Yes
2. No
10. Have you had medical problems as a result of your drug use (e.g., memory loss, hepatitis,
convulsions, bleeding, etc.)?
1. Yes
2. No
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APPENDIX G
UNIVERSITY ANNOUNCEMENT WEBPAGE
Online Survey “ADHD Stimulant Usage”- Win a $50 Amazon Gift Card!
Are you interested in winning a free $50 Amazon gift card? Then come participate in a study
investigating undergraduate ADHD stimulant medication usage! The survey will take no more
than 15 minutes to complete. All undergraduates over the age of 18 are invited to participate.
Upon completion of the survey, you will be entered into a raffle to win a $50 Amazon gift card.
Please click on the link below to complete the survey:

https://odu.co1.qualtrics.com/SE/?SID=SV_da64slsuf3lXSvP
If you have any questions, please send them to Alex Peterkin at apete047@odu.edu
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APPENDIX H
CONSENT FORM
PROJECT TITLE: ADHD Stimulant Usage
INTRODUCTION
The purpose of this form is to give you information that may affect your decision whether to say
YES or NO to participation in this research, and to record the consent of those who say YES.
RESEARCHERS
Alex Peterkin, Old Dominion University, Psychology Department
Val Derlega, PhD, Old Dominion University, Psychology Department
DESCRIPTION OF RESEARCH STUDY
This research investigates undergraduate students' use of ADHD stimulant medications,
including the use of such medications without a prescription or in a manner not recommended by
the prescription's instructions.
EXCLUSIONARY CRITERIA
To be eligible for this study you must be at least 18 years of age or older and an undergraduate
student at Old Dominion University
RISKS AND BENEFITS
RISKS: Participants are asked to report potentially sensitive information regarding their
substance-use behaviors; this may cause some psychological discomfort. You are free to leave
any question blank that you do not feel comfortable answering.
BENEFITS: There are no direct benefits to participating in this study.
COSTS AND PAYMENTS
There are no costs to participate in this study. If you decide to participate in this study, you will
be entered into a raffle for a $50 Amazon gift card.
NEW INFORMATION
If the researchers find new information during this study that would reasonably change your
decision about participating, then they will make this available to you.
CONFIDENTIALITY
All information obtained about you in this study is strictly confidential unless disclosure is
required by law. The researchers will take reasonable steps to keep private information, such as
surveys and demographic data, confidential. The results of this study may be used in reports,
presentations, and publications, but the researcher will not identify you.
WITHDRAWAL PRIVILEGE
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It is OK for you to say NO. Even if you say YES now, you are free to say NO later, and walk
away or withdraw from the study at any time. Your decision will not affect your relationship
with Old Dominion University, or otherwise cause a loss of benefits to which you might
otherwise be entitled. The researchers reserve the right to withdraw your participation in this
study, at any time, if they observe potential problems with your continued participation.
VOLUNTARY PARTICIPATION
By participating in this research study, you are saying several things. You are saying that you
have read this form or have had it read to you, that you are satisfied, and you understand this
form, the research study, and its risks and benefits. If you have any questions later on, please
contact the researcher:
Alex Peterkin at apete047@odu.edu
Val Derlega at vderlega@odu.edu
DO YOU CONSENT TO PARTICIPATE IN THIS RESEARCH?
 YES
 NO
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APPENDIX I
DEBRIEFING PAGE
DEBRIEFING
In the study you just participated in, we were interested in information regarding undergraduate
ADHD stimulant misuse. This is the use of ADHD stimulants by someone who either doesn't
have a prescription for that medication or who does have a prescription, but uses the medication
in a manner not recommended by the prescription's instructions.
If you would like to make any comments regarding this study or provide feedback that may
improve future studies on this topic, you may do so here

SUBSTANCE ABUSE RESOURCES
ADHD stimulant misuse is thought to be a method used by students to improve academic
performance and does not seem to be associated with short- or long-term consequences of
addiction and dependency. Despite this, the use of stimulant medications without a prescription
or in a manner that deviates from the prescription's instructions is considered illegal drug use by
the Controlled Substances Act (CSA) and may have some potentially serious health
consequences.
If you or anyone you know would like to seek help for substance abuse problems, please contact
any of the following resources:
ODU Counseling and Human Services
110 Education Building
Norfolk, VA, 23529
757-683-3326
Real Solutions of Virginia
5900 East Virginia Blvd
Janaf Office Building, Suite 101
Norfolk, VA, 23502
757-351-0693
The Counseling Center
400 North Center Dr
Building 3, Suite 202
Norfolk, VA, 23502
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757-461-4141
ADHD
Additionally, we and many other researchers believe that ADHD stimulant misuse may be a
form of self-treatment for undiagnosed ADHD. If you feel that you may be suffering from
problems with inattention, hyperactivity, distractibility, or impulsivity that is interfering your
daily functioning, social interactions, or school or job performance, please discuss this with your
primary care physician or contact ODU Student Health Services at 757-683-3132.

THANK YOU FOR YOUR PARTICIPATION AND COMPLETION OF THE SURVEY!
REMEMBER THAT THERE IS NO WAY TO LINK THE ANSWERS YOU GAVE HERE TO
YOUR NAME OR ANY OTHER IDENTIFIERS. IF YOU HAVE ANY QUESTIONS
REGARDING THE STUDY, PLEASE CONTACT ALEX PETERKIN AT
APETE047@ODU.EDU OR VAL VERLEGA AT VDERLEGA@ODU.EDU. PLEASE
CONTINUE TO THE NEXT PAGE AND YOU WILL BE REDIRECTED TO THE RAFFLE
FOR THE $50 AMAZON GIFT CARD.
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